Article
Enhancement of α5-containing γ-aminobutyric acid type A receptors by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6) is abolished by the β3(N265M) mutation.
Anesthesia and analgesia - 1 Dec 2014
Burkat Paul M, Lor Chong, Perouansky Misha, Pearce Robert A
Abstract excerpt
BACKGROUND: Modulation of γ-aminobutyric acid type A receptors (GABAARs) by general anesthetics may contribute to their ability to produce amnesia. Receptors containing α5 subunits, which mediate tonic and slow synaptic inhibition, are co-localized with β3 and γ2 subunits in dendritic layers of the hippocampus and are sensitive to low (amnestic) concentrations of anesthetics. Because α5 and β3 subunits influence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.